◉ HEADLINES

human trials

Promising Malaysian cancer vaccine awaits funding to begin long-delayed human trials

Seven years on, researchers say strong preclinical results persist, but lack of funding continues to hold back critical next-stage testing

Nipah virus: Oxford begins human trials for vaccine

The 51-patient trial will examine immune responses of people aged 18 to 55 to the vaccine, and more will be carried out later in a Nipah-affected country.

◉ Popular

Three JDT players banned following FIFA ruling: MFL CEO

League to enforce suspensions as FAM prepares appeal over FIFA’s ruling on heritage player

End of Bumiputera majority stake? Sunway makes RM3.15 per share takeover offer for IJM Corp

Despite earlier denials, Sunway’s bid to acquire IJM Corp could reshape Malaysia’s construction sector

OCM in the spotlight again: Skechers collab draws flak after brand linked to Israel

With shoe sponsorship amounting to almost RM200,000, Datuk Nazifuddin Najib says sports should be free from any agenda as the aim is to provide comfort to athletes

Copyright © 2023. All rights reserved.